Periodic Reporting for period 4 - TREAT-NPM1-AML (Improving therapy of NPM1-mutated AML)

Acute myeloid leukemia (AML) accounts for approximately 15,000 new cases/year in Europe. About 40-50% of AML patients (age 18-60 years) can be cured using conventional chemotherapy and allogeneic hematopoietic stem cell transplantation. However, AML is curable only in 5-10% of...